Intramyocardial injection of skeletal myoblasts: Long-term follow-up with pressure-volume loops

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue SUPPL. 1, 2006, Pages

  Steendijk, Paul ^a   Smits, Pieter C ^b   Valgimigli, Marco ^c   van der Giessen, Willem J ^c   Onderwater, Emile E M ^c   Serruys, Patrick W ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Medisch Centrum Rijnmond Zuid   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cell transplantation; Heart failure; Left ventricular function; Myoblasts; Pressure volume loops

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MUSCLE BIOPSY; MYOBLAST; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CELLS, CULTURED; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS; MALE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; STROKE VOLUME; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33644628689     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0416     Document Type: Article

References (33)

1. Tambara K et al. (2003) Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108 (Suppl 1): II259-II263
2. Taylor DA et al. (1998) Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933
3. Jain M et al. (2001) Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1927
4. Ghostine S et al. (2002) Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 (Suppl 1): I131-I136
5. Thompson RB et al. (2003) Comparison of intracardiac cell transplantation: Autologous skeletal myoblasts versus bone marrow cells. Circulation 108 (Suppl 1): II264-II271
6. Murtuza B et al. (2004) Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 101: 4216-4221
7. + progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44: 458-463
8. Quaini F et al. (2002) Chimerism of the transplanted heart. N Engl J Med 346: 5-15
9. Leobon B et al. (2003) Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 100: 7808-7811
10. Rubart M et al. (2004) Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114: 775-783
11. Hagège AA et al. (2001) Regeneration of the myocardium: A new role in the treatment of ischemic heart disease? Hypertension 38: 1413-1415
12. Pagani FD et al. (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879-888
13. Smits PC et al. (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069
14. Menasché P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083
15. Siminiak T et al. (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 148: 531-537
16. Makkar RR et al. (2003) Stem cell therapy for myocardial repair: Is it arrhythmogenic? J Am Coll Cardiol 42: 2070-2072
17. Herreros J et al. (2003) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24: 2012-2020
18. Criteria Committee of the New York Heart Association. (1994) Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, edn 9, 253-256. Boston: Little, Brown.
19. Baan J et al. (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70: 812-823
20. Steendijk P et al. (2001) Hypertonic saline method accurately determines parallel conductance for dualfield conductance catheter. Am J Physiol Heart Circ Physiol 281: H755-H763
21. Kass DA et al. (1988) Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 15: 192-202
22. Steendijk P et al. (1998) Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart. J Am Coll Cardiol 32: 816-826
23. Glower DD et al. (1985) Linearity of the Frank-Starling relationship in the intact heart: The concept of preload recruitable stroke work. Circulation 71: 994-1009
24. Little WC et al. (1989) Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. Circulation 80: 1378-1387
25. Menasché P (2004) Cellular transplantation: Hurdles remaining before widespread clinical use. Curr Opin Cardiol 19: 154-161
26. Muller-Ehmsen J et al. (2002) Cellular cardiomyoplasty - a novel approach to treat heart disease. Congest Heart Fail 8: 220-227
27. Menasché P (2003) Skeletal muscle satellite cell transplantation. Cardiovasc Res 58: 351-357
28. Koh GY et al. (1993) Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 92: 1548-1554
29. Hagége AA et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491-492
30. Dowell JD et al. (2003) Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58: 336-350
31. Menasché P (2005) Skeletal myoblast for cell therapy. Coron Artery Dis 16: 105-110
32. Chachques JC et al. (2004) Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 (Suppl 1): S29-S33
33. Scorsin M et al. (2000) Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119: 1169-1175